82 related articles for article (PubMed ID: 11162602)
21. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.
Bektic J; Pfeil K; Berger AP; Ramoner R; Pelzer A; Schäfer G; Kofler K; Bartsch G; Klocker H
Prostate; 2005 Sep; 64(4):332-40. PubMed ID: 15754346
[TBL] [Abstract][Full Text] [Related]
22. PPARalpha ligands cause lymphocyte depletion and cell cycle block and this is associated with augmented TRB3 and reduced Cyclin B1 expression.
Morse E; Selim E; Cunard R
Mol Immunol; 2009 Oct; 46(16):3454-61. PubMed ID: 19748123
[TBL] [Abstract][Full Text] [Related]
23. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
24. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53.
Park MJ; Kim EH; Park IC; Lee HC; Woo SH; Lee JY; Hong YJ; Rhee CH; Choi SH; Shim BS; Lee SH; Hong SI
Int J Oncol; 2002 Aug; 21(2):379-83. PubMed ID: 12118335
[TBL] [Abstract][Full Text] [Related]
25. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
26. The modulation of radiation-induced cell death by genistein in K562 cells: activation of thymidine kinase 1.
Jeong MH; Jin YH; Kang EY; Jo WS; Park HT; Lee JD; Yoo YJ; Jeong SJ
Cell Res; 2004 Aug; 14(4):295-302. PubMed ID: 15353126
[TBL] [Abstract][Full Text] [Related]
27. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways.
Ray G; Dhar G; Van Veldhuizen PJ; Banerjee S; Saxena NK; Sengupta K; Banerjee SK
Biochemistry; 2006 Mar; 45(11):3703-13. PubMed ID: 16533053
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
29. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS
Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845
[TBL] [Abstract][Full Text] [Related]
30. SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells.
Pang LP; Huang W; Sun Q; Guo W; Li RT; Cui JR
Anticancer Drugs; 2008 Feb; 19(2):167-74. PubMed ID: 18176113
[TBL] [Abstract][Full Text] [Related]
31. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
[TBL] [Abstract][Full Text] [Related]
32. [Effect of cisplatin on cell cycle regulators].
Nishio K; Saijo N
Gan To Kagaku Ryoho; 1994 Feb; 21(3):289-94. PubMed ID: 8109984
[TBL] [Abstract][Full Text] [Related]
33. Expression profiling of cyclin B1 and D1 in cervical carcinoma.
Zhao M; Kim YT; Yoon BS; Kim SW; Kang MH; Kim SH; Kim JH; Kim JW; Park YW
Exp Oncol; 2006 Mar; 28(1):44-8. PubMed ID: 16614707
[TBL] [Abstract][Full Text] [Related]
34. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
Flanagan WM; Su LL; Wagner RW
Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
[TBL] [Abstract][Full Text] [Related]
35. Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.
Janss AJ; Maity A; Tang CB; Muschel RJ; McKenna WG; Sutton L; Phillips PC
Neuro Oncol; 2001 Jan; 3(1):11-21. PubMed ID: 11305412
[TBL] [Abstract][Full Text] [Related]
36. Aurora-A interacts with Cyclin B1 and enhances its stability.
Qin L; Tong T; Song Y; Xue L; Fan F; Zhan Q
Cancer Lett; 2009 Mar; 275(1):77-85. PubMed ID: 19028417
[TBL] [Abstract][Full Text] [Related]
37. The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents.
Rasmussen LJ; Rasmussen M; Lützen A; Bisgaard HC; Singh KK
Exp Cell Res; 2000 May; 257(1):127-34. PubMed ID: 10854060
[TBL] [Abstract][Full Text] [Related]
38. Differences in cyclin B1 expression in cells blocked in the G2M phase after treatment with anticancer agent. New three-parametric flow cytometric analysis.
Faretta M; Bergamaschi D; Ronzoni S; D'Incalci M; Erba E
Eur J Histochem; 1997; 41 Suppl 2():73-4. PubMed ID: 9859790
[No Abstract] [Full Text] [Related]
39. Critical role of cyclin B1/Cdc2 up-regulation in the induction of mitotic prometaphase arrest in human breast cancer cells treated with 2-methoxyestradiol.
Choi HJ; Zhu BT
Biochim Biophys Acta; 2012 Aug; 1823(8):1306-15. PubMed ID: 22580043
[TBL] [Abstract][Full Text] [Related]
40. A decrease in cyclin B1 levels leads to polyploidization in DNA damage-induced senescence.
Kikuchi I; Nakayama Y; Morinaga T; Fukumoto Y; Yamaguchi N
Cell Biol Int; 2010 May; 34(6):645-53. PubMed ID: 20222868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
